8-Isoprostaglandin F(2α), a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats

Gastroenterology

Volumn 112, Issue 1, 1997, Pages 208-213

  Marley, R ^a   Harry, D ^a   Anand, R ^a   Fernando, B ^a   Davies, S ^a   Moore, K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA DERIVATIVE; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; HYDRAZINE DERIVATIVE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN ENDOPEROXIDE; PROSTAGLANDIN F2 ALPHA; THROMBOXANE A2; VASOCONSTRICTOR AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; LIPID PEROXIDATION; LIVER BLOOD FLOW; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; ANIMAL; DRUG ANTAGONISM; EXPERIMENTAL LIVER CIRRHOSIS; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; DINOPROST; F2-ISOPROSTANES; HYDRAZINES; LIPID PEROXIDATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PORTAL PRESSURE; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0030614779     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(97)70237-3     Document Type: Article

References (29)